Meyka AI API is live for developers.Start building.
Advertisement
Alvotech

Alvotech (ALVOW) Stock Overview

Explore Alvotech’s financial performance, market position, analyst ratings, and future outlook.

ALVOWNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.18
$0.03(13.10%)
U.S. Market opens in 47h 4m
Advertisement

Alvotech (ALVOW)

Meyka AI Score

Z

Key Financials

Market Cap65.6M
P/E Ratio-14.55
EPS (TTM)N/A
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.54
3 Months$0.00
1 Year Target$0.00

ALVOW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alvotech (ALVOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.55 and a market capitalization of 65.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.05%
5-Day Change
5.05%
1-Month Change
-36.35%
3-Month Change
-42.49%
6-Month Change
-67.68%
Year-to-Date (YTD) Change
-67.67%
1-Year Change
-90.79%
3-Year Change
-81.24%
5-Year Change
-81.57%
All-Time (Max) Change
-80.90%

Contact Information

354 422 4500
Saemundargata 15-19, Luxembourg, NaN, 102

Company Facts

10,120 Employees
IPO DateJun 16, 2022
CountryIS
Actively Trading

Frequently Asked Questions